What question did this study set out to answer?

To determine the role of eukaryotic elongation factor 2 (eEF2) expression in the tumorigenesis and cell cycle regulation of gastrointestinal cancers.

April 2, 2009International Journal of OncologyOpen Access

Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle

View Full Paper

Ask AI

Bookmark

To determine the role of eukaryotic elongation factor 2 (eEF2) expression in the tumorigenesis and cell cycle regulation of gastrointestinal cancers.
Assessed eEF2 protein expression using immunohistochemistry in gastric (n=14) and colorectal (n=24) cancer tissues, and sequenced eEF2 exons in 12 tumors (6 gastric, 6 colorectal).
Knocked down eEF2 using short-hairpin RNA (shEF2) in gastric (AZ-521, MKN28) and colon (SW620) cancer cell lines, measuring cell growth and cell cycle phases via flow cytometry.
Engineered forced eEF2 expression in AZ-521 cells to evaluate cell cycle dynamics, downstream signaling markers (Akt, cdc2, eEF2 kinase), and in vivo tumorigenicity in mouse xenografts.
eEF2 was overexpressed in 92.9% (13 of 14) of gastric and 91.7% (22 of 24) of colorectal cancer specimens, with no mutations detected across exons in 12 analyzed tumors.
shRNA-mediated eEF2 knockdown significantly suppressed cell proliferation, triggered G2/M phase cell cycle arrest, inactivated Akt and cdc2, and activated eEF2 kinase across all tested cell lines.
Forced eEF2 expression enhanced cancer cell growth by accelerating G2/M cell cycle progression, activated Akt and cdc2, inhibited eEF2 kinase, and significantly enhanced in vivo tumor growth in xenograft models.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Preclinical study reveals eEF2 overexpression accelerates G2/M cell cycle progression in gastrointestinal cancer models, indicating a direct link between translation elongation and tumor growth.

Cite This Study

A 2009 study studied this question.

synapsesocial.com/papers/6a7e03bec108c8d3ff04641f https://doi.org/10.3892/ijo_00000246

View Full Paper

Ask AI

Bookmark

Implication

Preclinical study reveals eEF2 overexpression accelerates G2/M cell cycle progression in gastrointestinal cancer models, indicating a direct link between translation elongation and tumor growth.

Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle

Key Points

Discussion

Implication

Cite This Study

Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider